within Pharmacolibrary.Drugs.ATC.C;

model C05AE01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.883333333333333e-05,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0033,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0256,
    k12             = 1.08,
    k21             = 1.08
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C05AE01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Glyceryl trinitrate, also known as nitroglycerin, is a nitrate vasodilator. It is commonly used for the prevention and treatment of angina pectoris (chest pain) and heart failure. Glyceryl trinitrate works by releasing nitric oxide, which relaxes vascular smooth muscle, resulting in vasodilation. The drug is approved and widely used in clinical practice, administered via several routes including sublingual, intravenous, and transdermal.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Twiner, MJ, et al., &amp; Levy, PD (2022). Nitroglycerin Use in the Emergency Department: Current Perspectives. <i>Open access emergency medicine : OAEM</i> 14 327–333. DOI:<a href=&quot;https://doi.org/10.2147/OAEM.S340513&quot;>10.2147/OAEM.S340513</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35847764/&quot;>https://pubmed.ncbi.nlm.nih.gov/35847764</a></p></li><li><p>Sorkin, EM, et al., &amp; Romankiewicz, JA (1984). Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy. <i>Drugs</i> 27(1) 45–80. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198427010-00003&quot;>10.2165/00003495-198427010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6420139/&quot;>https://pubmed.ncbi.nlm.nih.gov/6420139</a></p></li><li><p>Bogaert, MG (1987). Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations. <i>Clinical pharmacokinetics</i> 12(1) 1–11. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198712010-00001&quot;>10.2165/00003088-198712010-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3102143/&quot;>https://pubmed.ncbi.nlm.nih.gov/3102143</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C05AE01;
